{"id":45335,"date":"2022-06-22T01:01:40","date_gmt":"2022-06-21T23:01:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/quidel-corporation-and-the-american-heart-association-join-forces-to-advance-education-and-awareness-of-heart-disease-in-san-diego-county\/"},"modified":"2022-06-22T01:01:40","modified_gmt":"2022-06-21T23:01:40","slug":"quidel-corporation-and-the-american-heart-association-join-forces-to-advance-education-and-awareness-of-heart-disease-in-san-diego-county","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/quidel-corporation-and-the-american-heart-association-join-forces-to-advance-education-and-awareness-of-heart-disease-in-san-diego-county\/","title":{"rendered":"Quidel Corporation and the American Heart Association join forces to Advance Education and Awareness of Heart Disease in San Diego County"},"content":{"rendered":"
\n

\nThe three-year, $750,000 commitment is expected to improve overall health and save lives<\/i><\/b>\n<\/p>\n

<\/a><\/p>\n

SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (NASDAQ: QDEL) (\u201cQuidelOrtho\u201d) <\/b>\u2014 QuidelOrtho announces that its subsidiary, Quidel Corporation, is collaborating with the American Heart Association, the leading voluntary health organization devoted to a world of longer and healthier lives, to improve the health of San Diego residents and deconstruct barriers to equitable health in our communities. Quidel Corporation will invest funding totaling $750,000 and support over the next three years as the American Heart Association approaches their centennial anniversary in 2024.\n<\/p>\n

\n\u201cThe work we do at the American Heart Association to promote cardiovascular and brain health, prevent heart disease and stroke, support research and provide resources to help people live longer, healthier lives \u2013 no matter where they live \u2013 is possible because of the supporters like Quidel,\u201d said Dr. Robert Stein, cardiologist and Board President of the American Heart Association San Diego Division.\n<\/p>\n

\nCardiovascular disease is the No. 1 killer in the United States and about 2,150 Americans die each day from it. Stroke, the No. 5 killer in the U.S. and a leading cause of severe disability, claims the lives of nearly 219,000 Americans each year. Together, the American Heart Association and Quidel Corporation will work to create collective, transformational change inspired by engaging local businesses, their employees, the community, and youth in year-round initiatives that are designed to improve their physical health and emotional wellbeing.\n<\/p>\n

\n\u201cCollaborating with the AHA San Diego Division helps us fulfill our responsibility of supporting our community, and there\u2019s no better time to announce this collaboration than now,\u201d said Douglas Bryant, Chairman and CEO of QuidelOrtho Corporation. \u201cHeart disease is the leading cause of death in the U.S., and for many diseases such as heart failure, the prevalence is only increasing. As we remain dedicated to addressing unmet needs in diseases, our top priority continues to be to elevate attention to heart disease. We look forward to continuing to work together with the AHA to advance their goals and initiatives.\u201d\n<\/p>\n

\nAs part of the collaboration, Quidel will invest funding and support for several campaigns and initiatives led by AHA San Diego Division. They will include:\n<\/p>\n